Rating Change
HC Wainwright & Co. reiterated its Sell rating on Sarepta Therapeutics, Inc. (NASDAQ:SRPT) on October 05, 2026.
reiterateNASDAQ:SRPT
HC Wainwright & Co. Reiterates Sell Rating on Sarepta Therapeutics, Inc. (SRPT)
HC Wainwright & Co. reiterated its Sell rating on Sarepta Therapeutics, Inc.
At publication ·
What changed
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) · reiterate
- Firm
- HC Wainwright & Co.
- Rating
- Sell to Sell
- Price at event
- $17.49
- Market capitalization
- $2.1B
At a glance
Key takeaways
- HC Wainwright & Co. reiterated a Sell rating on Sarepta Therapeutics (SRPT) on October 5, 2026.
Market Context
Sarepta Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $17.49 with a market capitalization of $2.1B.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Sarepta Therapeutics, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Sarepta Therapeutics, Inc.
Among the 10 most recent ratings: 3 Buy, 2 Hold, 5 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 05, 2026 | HC Wainwright & Co. | Sell | N/A |
| Sep 30, 2026 | JP Morgan | Neutral | N/A |
| Sep 28, 2026 | Needham | Underperform | N/A |
| Jul 09, 2026 | Piper Sandler | Neutral | N/A |
| Jul 09, 2026 | Wolfe Research | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View SRPT Stock Page
Frequently Asked Questions
What does the Sell rating mean for SRPT?
A rating of Sell from HC Wainwright & Co. reflects the analyst's outlook on Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SRPT forecast page.